ARMET-like Protein 1 Market, By Product Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

ARMET-like Protein 1 Market size was valued at US$ 84.7 Million in 2025, expanding at a CAGR of 8.1% from 2026 to 2033.

The ARMET-like Protein 1 market consists of research-grade recombinant cerebral dopamine neurotrophic factor (CDNF), also known as ARMETL1, which is mostly offered as a purified laboratory reagent rather than a therapeutic entity, including full-length protein, specific fragments, tagged versions, bacterial and mammalian expression systems, and other variants that are typically differentiated by analytical purity, targeting neuroscience, neuroprotection, neuronal signaling, protein biology, and various assays. In 2025, experimental evidence demonstrated an increased viability of neurons by 75% following trophic deprivation in three experimental models, expanding a body of evidence supporting the therapeutic utility of CDNF, which has implications for research product selection based on quality, activity, and reproducibility.

ARMET-like Protein 1 Market- Market Dynamics

Expanding Experimental Evidence Is Strengthening CDNF Reagent Utilization

Increasing mechanistic evidence supports the introduction of functional CDNF into research laboratory practice. As shown by a 2025 study published in the Journal of Neurochemistry, CDNF promoted neuritogenesis and protected neurons in dorsal root ganglion models through PI3K/AKT/mTOR signaling. Notably, the growth factor treatment resulted in cell viability rates improving from 46% to 75% as compared to 77% for NGF. In addition, the study also reported increased neurite lengths of about 390 micrometers versus under 200 micrometers for the inactive CDNF-ΔKTEL mutant. Overall, such findings enhance the credibility of research-grade recombinant proteins, thus contributing to the rising demand for CDNF.

ARMET-like Protein 1 Market- Segmentation Analysis:

The Global ARMET-like Protein 1 Market is segmented on the basis of Product Type, Application, End User, and Region.

By product type, purity will play a critical role in the product category of ARMET-like Protein 1 since the quality of research may depend on whether the result was achieved using a product without impurities, with a standard composition, and appropriate functionality. Thus, products with low purity (>95%) may only be used for exploratory testing, screening, and other research areas that do not require strict control over the properties of the substance under study. At the same time, items with high purity (>95%) may be used for mechanistic and structural analysis as well as other studies requiring a high level of control. Companies only offer human CDNF protein with high (>95%) purity, which is confirmed by SDS-PAGE or HPLC, while medium purity is represented by products from other companies with a purity level of approximately 85%. The former is a preferred choice among customers who specify their requirements in terms of impurity content and have a clear idea of the characteristics they need.

By application, research centers, universities, biotechnology companies, and contract research organizations are the most significant end users of human CDNF protein. Representatives of the first category focus on the quality of research, its reproducibility, the presence of biological activity, and sufficient supply to conduct the necessary experiments. Academic research sites, on the other hand, reflect a wide range of needs in terms of CDNF, from fundamental research to specific applications related to neurons. Biotechnology companies and contract research organizations represent another emerging segment, as they are interested in preclinical studies. In 2025, research conducted by the research center of the Federal University of Rio de Janeiro investigating the effect of CDNF on the dorsal root ganglion and a separate group from Southwest Medical University studying the signaling pathway of CDNF will be published. Thus, with a high degree of certainty academic institutions remain the largest end users of CDNF protein.

ARMET-like Protein 1 Market- Geographical Insights

North America offers a favorable environment for ARMET-like Protein 1 research because its biomedical ecosystem combines major research institutions, established neuroscience programs, and a broad supplier base for recombinant proteins. NIH data recorded 44,002 principal investigators funded through research grants in 2025, including 18,100 women and 25,902 men, illustrating the scale of the region's publicly supported research community. This infrastructure supports investigations linking protein biology with neurodegenerative and neurological disorders. Suppliers serving the region differentiate through stringent purity specifications, defined expression systems, functional validation, and technical documentation. North America consequently remains an important center for premium CDNF research reagents and translational neuroscience experimentation.

Europe continues to be relevant through established neuroscience services, pan-European academic cooperation, and translational analysis of the neuroprotective properties of CDNF. In 2025, the European Research Executive Agency accepted more than 3,400 proposals throughout 5 calls on Horizon Europe, covering scientific instruments/services in support of health research; the field extended toward the therapeutic development of CDNF analogs, and in January 2025, the University of Helsinki launched a preclinical development study examining small-molecule CDNF/MANF analogs. These are not measures of the actual quantities of reagent used, but they suggest that interest in CDNF continues and indicate a sizable European organizational base for research using specialized proteins and experimental applications based on them.

ARMET-like Protein 1 Market- Competitive Landscape:

The competitive landscape in the field of life-science reagent is fragmented, where vendors offering similar products differentiate from one another by providing various expression platforms, construct engineering, molecular tags, endotoxin levels, purity, functional validation, and application support, rather than a dominant Protein 1 franchise of the ARMET-like. Abcam, for instance, provides more than one human CDNF protein with an endotoxin level below 0.01 EU/mg and over 95% purity, while Proteintech offers ARMETL1 recombinant protein with bacterial expression systems and the availability of custom order options. Other suppliers also provide HEK293-expressed and His-tagged or Fc-tagged proteins with the option of choosing between different tags and expression systems according to particular research needs. his product diversity places greater emphasis on reproducibility, lot consistency, technical documentation, and application-specific validation. Supplier credibility and technical support therefore will be key consideration when a laboratory chooses a particular supplier.

Recent Developments:

In January 2025, Herantis Pharma reported findings from the HER-096 Phase 1a first-in-human study in 60 healthy volunteers demonstrating blood-brain-barrier penetration data in their development.

In August 2025, scientists from the Federal University of Rio de Janeiro released study results indicating CDNF promoted neuritogenesis and neuroprotection of dorsal root ganglion neurons via the PI3K/AKT/mTOR signaling pathway.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARMET-LIKE PROTEIN 1 MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbexa Ltd
MyBioSource
Alomone Labs
Antibodies.com
Sigma-Aldrich
Syd Labs
Abcam
Thermo Fisher Scientific
Novus Biologicals
Bio-Techne (R&D Systems)
Cell Signaling Technology
Proteintech Group
GeneTex
Biorbyt
Cusabio
Others

GLOBAL ARMET-LIKE PROTEIN 1 MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

Purity<95%
Purity >=95%

GLOBAL ARMET-LIKE PROTEIN 1 MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

Research Center
University
Others

GLOBAL ARMET-LIKE PROTEIN 1 MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

Academic & research institutes
Contract research organizations (CROs)
Pharmaceutical & biotech companies
Diagnostic laboratories
Others

GLOBAL ARMET-LIKE PROTEIN 1 MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV7358

1. ARMET-like Protein 1 Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. ARMET-like Protein 1 Market Snippet by Type
- 2.1.2. ARMET-like Protein 1 Market Snippet by Application
- 2.1.3. ARMET-like Protein 1 Market Snippet by End User
- 2.1.4. ARMET-like Protein 1 Market Snippet by Country
- 2.1.5. ARMET-like Protein 1 Market Snippet by Region
2.2. Competitive Insights

3. ARMET-like Protein 1 Key Market Trends

3.1. ARMET-like Protein 1 Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. ARMET-like Protein 1 Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. ARMET-like Protein 1 Market Opportunities
3.4. ARMET-like Protein 1 Market Future Trends

4. ARMET-like Protein 1 Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. ARMET-like Protein 1 Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. ARMET-like Protein 1 Market Landscape

6.1. ARMET-like Protein 1 Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. ARMET-like Protein 1 Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
- 7.1.2. Purity<95%
- 7.1.3. Purity >=95%

8. ARMET-like Protein 1 Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. Research Center
- 8.1.3. University
- 8.1.4. Others

9. ARMET-like Protein 1 Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 9.1.2. Academic & research institutes
- 9.1.3. Contract research organizations (CROs)
- 9.1.4. Pharmaceutical & biotech companies
- 9.1.5. Diagnostic laboratories
- 9.1.6. Others

10. ARMET-like Protein 1 Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. ARMET-like Protein 1 Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. ARMET-like Protein 1 Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.16. Denmark
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.16.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.17. Rest of Europe
  - 10.3.17.1. Overview
  - 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. ARMET-like Protein 1 Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.15. Taiwan
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.15.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.16. Vietnam
  - 10.4.16.1. Overview
  - 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.16.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.17. Rest of APAC
  - 10.4.17.1. Overview
  - 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. ARMET-like Protein 1 Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. ARMET-like Protein 1 Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.13. Iran
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.13.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.14. Qatar
  - 10.6.14.1. Overview
  - 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.14.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.15. Rest of MEA
  - 10.6.15.1. Overview
  - 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 10.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  - 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- ARMET-like Protein 1 Industry

11.1. Competitive Benchmarking
- 11.1.1. Competitive Dashboard
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Abbexa Ltd
- 11.2.2. MyBioSource
- 11.2.3. Alomone Labs
- 11.2.4. Antibodies.com
- 11.2.5. Sigma-Aldrich
- 11.2.6. Syd Labs
- 11.2.7. Abcam
- 11.2.8. Thermo Fisher Scientific
- 11.2.9. Novus Biologicals
- 11.2.10. Bio-Techne (R&D Systems)
- 11.2.11. Cell Signaling Technology
- 11.2.12. Proteintech Group
- 11.2.13. GeneTex
- 11.2.14. Biorbyt
- 11.2.15. Cusabio
- 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us